Scarica l'app Stockscreener
1.27
2.31%
-0.03
Dopo l'orario di chiusura:
1.33
0.06
+4.72%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.30
Aprire:
$1.31
Volume 24 ore:
40,991
Relative Volume:
0.37
Capitalizzazione di mercato:
$9.57M
Reddito:
-
Utile/perdita netta:
$-25.56M
Rapporto P/E:
-0.2442
EPS:
-5.2
Flusso di cassa netto:
$-19.35M
1 W Prestazione:
-4.51%
1M Prestazione:
-18.06%
6M Prestazione:
-84.22%
1 anno Prestazione:
-46.19%
Intervallo 1D:
$1.26
$1.31
Intervallo di 1 settimana:
$1.26
$1.425
Portata 52W:
$0.62
$9.56
Biovie Inc Stock (BIVI) Company Profile
Nome
Biovie Inc
Settore
Industria
Telefono
775-888-3162
Indirizzo
680 W NYE LANE, CARSON CITY
Confronta BIVI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.27 | 9.80M | 0 | -25.56M | -19.35M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-07-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-01-15 | Iniziato | B. Riley Securities | Buy |
Biovie Inc Borsa (BIVI) Ultime notizie
Why BioVie Inc. stock is rated strong buyJuly 2025 Short Interest & Fast Moving Trade Plans - ulpravda.ru
Will BioVie Inc. stock benefit from infrastructure spendingWeekly Profit Summary & Technical Pattern Based Buy Signals - ulpravda.ru
Is BioVie Inc. stock cheap compared to fundamentalsJuly 2025 Outlook & Safe Entry Point Identification - ulpravda.ru
Why retail investors pile into BioVie Inc. stockQuarterly Profit Review & Safe Capital Investment Plans - ulpravda.ru
Will BioVie Inc. stock see insider buyingMarket Activity Report & Expert Approved Momentum Ideas - ulpravda.ru
Stock Analysis: How supply chain issues affect BioVie Inc. stockNew Guidance & Fast Exit Strategy with Risk Control - ulpravda.ru
BioVie completes enrollment for Parkinson’s drug trial By Investing.com - Investing.com Australia
BioVie completes enrollment for Parkinson’s drug trial - Investing.com
BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson’s Disease - Yahoo Finance
Is BioVie Inc. stock dividend yield sustainableSmall Cap Stock Opportunities & Affordable Market Insights - ulpravda.ru
Aug Shorts: Why BioVie Inc stock is rated strong buyWeekly Stock Analysis & High Accuracy Trade Signal Alerts - moha.gov.vn
HALPER SADEH LLC ENCOURAGES BIOVIE INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - The Malaysian Reserve
BioVie (NASDAQ:BIVI) Trading Down 5.8% – What’s Next? - Defense World
BioVie Inc Stock Analysis and ForecastEconomic Impact on Stocks & Free Real-Time Stock Market Data - earlytimes.in
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Daily Commercial
Will BioVie Inc. stock outperform Dow Jones indexJuly 2025 Snapshot & Fast Gain Stock Trading Tips - ulpravda.ru
BioVie advances lead drug candidatesICYMI - Proactive financial news
Breakout Zone: Will BioVie Inc. stock outperform Dow Jones indexJobs Report & Reliable Price Breakout Alerts - Улправда
What Wall Street predicts for BioVie Inc. stock priceMarket Performance Summary & Stepwise Swing Trade Plans - Улправда
Aug Movers: How BioVie Inc. stock compares to industry benchmarksJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - Улправда
How BioVie Inc. stock compares to industry benchmarks2025 EndofYear Setup & Precise Buy Zone Identification - ulpravda.ru
Fund Flows: What momentum indicators show for BioVie Inc. stockJuly 2025 Outlook & Daily Chart Pattern Signal Reports - Улправда
What momentum indicators show for BioVie Inc. stockQuarterly Performance Summary & Technical Confirmation Trade Alerts - Улправда
BioVie advances Parkinson’s, long COVID, and liver disease programs ahead of 2026 - Proactive financial news
What makes BioVie (BIVI) a new buy stock - MSN
What Makes BioVie (BIVI) a New Buy Stock - sharewise.com
BioVie Inc. (BIVI) Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver DiseaseSlideshow (NASDAQ:BIVI) 2025-12-09 - Seeking Alpha
New to The Street Broadcasts Tonight on Bloomberg at 6:30 PM EST Featuring Roadzen, BioVie, and TY J Young Wealth - The Florida Times-Union
Breakout Watch: How BioVie Inc. stock compares to industry benchmarksPortfolio Performance Summary & Safe Capital Growth Trade Ideas - BỘ NỘI VỤ
Can BioVie Inc. stock sustain institutional interestJuly 2025 Review & Low Drawdown Trading Strategies - Newser
BioVie Inc. (BIVI) -5.7% in After-hours: Stock Declines Amid Routine Trading Conditions - Stocks Telegraph
BioVie (NASDAQ:BIVI) Shares Up 0.3% – Here’s What Happened - Defense World
BIVI SEC FilingsBiovie Inc 10-K, 10-Q, 8-K Forms - Stock Titan
[S-8] BIOVIE INC. Employee Benefit Plan Registration | BIVI SEC FilingForm S-8 - Stock Titan
BIVIW Insider Trading - Quiver Quantitative
BIVIW | BioVie Inc. Warrant Stock Data, Price & News - Quiver Quantitative
BioVie Inc. (BIVI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What drives BioVie Inc stock pricePrice Support Zones & Free Record-Breaking Gains - earlytimes.in
What catalysts could drive BioVie Inc. stock higherMarket Performance Summary & Consistent Growth Stock Picks - newser.com
Biotech Stocks Swing After Hours: Delcath Rises On Buyback, BioVie And Cassava Rebound - Nasdaq
Will BioVie Inc. stock outperform Nasdaq index2025 Market Overview & Daily Oversold Bounce Ideas - newser.com
How BioVie Inc. stock performs in stagflation2025 Momentum Check & Free Fast Entry Momentum Trade Alerts - newser.com
Biovie Inc Azioni (BIVI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):